Format
Sort by
Items per page

Send to

Choose Destination

Links from Gene

Items: 1 to 20 of 1888

1.

E-cadherin Downregulation and microRNAs in Sporadic Intestinal-Type Gastric Cancer.

Rossi T, Tedaldi G, Petracci E, Abou Khouzam R, Ranzani GN, Morgagni P, Saragoni L, Monti M, Calistri D, Ulivi P, Molinari C.

Int J Mol Sci. 2019 Sep 10;20(18). pii: E4452. doi: 10.3390/ijms20184452.

2.

E-cadherin is downregulated in benign prostatic hyperplasia and required for tight junction formation and permeability barrier in the prostatic epithelial cell monolayer.

Li F, Pascal LE, Stolz DB, Wang K, Zhou Y, Chen W, Xu Y, Chen Y, Dhir R, Parwani AV, Nelson JB, DeFranco DB, Yoshimura N, Balasubramani GK, Gingrich JR, Maranchie JK, Jacobs BL, Davies BJ, Hrebinko RL, Bigley JD, McBride D, Guo P, He D, Wang Z.

Prostate. 2019 Aug;79(11):1226-1237. doi: 10.1002/pros.23806. Epub 2019 Jun 18.

PMID:
31212363
3.

Exploring E-cadherin-peptidomimetics interaction using NMR and computational studies.

Civera M, Vasile F, Potenza D, Colombo C, Parente S, Vettraino C, Prosdocimi T, Parisini E, Belvisi L.

PLoS Comput Biol. 2019 Jun 3;15(6):e1007041. doi: 10.1371/journal.pcbi.1007041. eCollection 2019 Jun.

4.

Frequency of CDH1 germline variants and contribution of dietary habits in early age onset gastric cancer patients in Brazil.

Guindalini RSC, Cormedi MCV, Maistro S, Pasini FS, Branas PCAA, Dos Santos L, de Lima Pereira GF, de Bock GH, Saccaro DM, Katayama MLH, Faraj SF, Safatle-Ribeiro A, Ribeiro Junior U, Diz MDPE, de Gouvêa ACRC, Chammas R, Folgueira MAAK.

Gastric Cancer. 2019 Sep;22(5):920-931. doi: 10.1007/s10120-019-00945-9. Epub 2019 Mar 20.

5.

Association of clinicopathological features with E-cadherin (CDH1) gene-160 C>A promoter polymorphism in Turkish colorectal cancer patients.

Bahadir A, Eral G, Budak M, Shimamoto F, Korpinar MA, Erdamar S, Tuncel H.

J Cancer Res Ther. 2019 Jan-Mar;15(1):26-31. doi: 10.4103/jcrt.JCRT_1277_16.

6.

CDH1 somatic alterations in Mexican patients with diffuse and mixed sporadic gastric cancer.

Bustos-Carpinteyro AR, Oliveira C, Sousa A, Oliveira P, Pinheiro H, Carvalho J, Magaña-Torres MT, Flores-Miramontes MG, Aguilar-Lemarroy A, Jave-Suárez LF, Peregrina-Sandoval J, Cruz-Ramos JA, Sánchez-López JY.

BMC Cancer. 2019 Jan 14;19(1):69. doi: 10.1186/s12885-019-5294-0.

7.

E-Cadherin in Colorectal Cancer: Relation to Chemosensitivity.

Druzhkova I, Ignatova N, Prodanets N, Kiselev N, Zhukov I, Shirmanova M, Zagainov V, Zagaynova E.

Clin Colorectal Cancer. 2019 Mar;18(1):e74-e86. doi: 10.1016/j.clcc.2018.10.003. Epub 2018 Oct 16.

PMID:
30415989
8.

Does hypermethylation of CpG island in the promoter region of the E-cadherin gene increase the risk of lung cancer? A meta-analysis.

Sun Z, Liu G, Xu N.

Thorac Cancer. 2019 Jan;10(1):54-59. doi: 10.1111/1759-7714.12900. Epub 2018 Nov 3.

9.

Cleft lip/palate and hereditary diffuse gastric cancer: report of a family harboring a CDH1 c.687 + 1G > A germline mutation and review of the literature.

Obermair F, Rammer M, Burghofer J, Malli T, Schossig A, Wimmer K, Kranewitter W, Mayrbaeurl B, Duba HC, Webersinke G.

Fam Cancer. 2019 Apr;18(2):253-260. doi: 10.1007/s10689-018-0111-5. Review.

PMID:
30306390
10.

Role of E-cadherin in Progression of Oral Squamous Cell Carcinoma: A Retrospective Immunohistochemical Study.

Gupta A, Sharma S, Batra M, Abidullah M, Bhuvinder S, Katragadda P.

J Contemp Dent Pract. 2018 Sep 1;19(9):1105-1110.

PMID:
30287712
11.

Long noncoding RNA NSCLCAT1 increases non-small cell lung cancer cell invasion and migration through the Hippo signaling pathway by interacting with CDH1.

Zhao W, Zhang LN, Wang XL, Zhang J, Yu HX.

FASEB J. 2019 Jan;33(1):1151-1166. doi: 10.1096/fj.201800408R. Epub 2018 Aug 27.

PMID:
30148675
12.

E-cadherin signal sequence disruption: a novel mechanism underlying hereditary cancer.

Figueiredo J, Melo S, Gamet K, Godwin T, Seixas S, Sanches JM, Guilford P, Seruca R.

Mol Cancer. 2018 Aug 1;17(1):112. doi: 10.1186/s12943-018-0859-0.

13.

Single-nucleotide polymorphisms of the adherent junction component cadherin gene are associated with leukoaraiosis.

Yadav BK, Shin BS.

Gene. 2018 Nov 15;676:65-72. doi: 10.1016/j.gene.2018.07.007. Epub 2018 Jul 12.

PMID:
30017735
14.

The Role of E-Cadherin as a Prognostic Biomarker in Head and Neck Squamous Carcinoma: A Systematic Review and Meta-Analysis.

Yazdani J, Ghavimi MA, Jabbari Hagh E, Ahmadpour F.

Mol Diagn Ther. 2018 Oct;22(5):523-535. doi: 10.1007/s40291-018-0351-y.

PMID:
30006812
15.

Loss of E-cadherin Enhances IGF1-IGF1R Pathway Activation and Sensitizes Breast Cancers to Anti-IGF1R/InsR Inhibitors.

Nagle AM, Levine KM, Tasdemir N, Scott JA, Burlbaugh K, Kehm J, Katz TA, Boone DN, Jacobsen BM, Atkinson JM, Oesterreich S, Lee AV.

Clin Cancer Res. 2018 Oct 15;24(20):5165-5177. doi: 10.1158/1078-0432.CCR-18-0279. Epub 2018 Jun 25.

16.

Hereditary lobular breast cancer with an emphasis on E-cadherin genetic defect.

Corso G, Figueiredo J, La Vecchia C, Veronesi P, Pravettoni G, Macis D, Karam R, Lo Gullo R, Provenzano E, Toesca A, Mazzocco K, Carneiro F, Seruca R, Melo S, Schmitt F, Roviello F, De Scalzi AM, Intra M, Feroce I, De Camilli E, Villardita MG, Trentin C, De Lorenzi F, Bonanni B, Galimberti V.

J Med Genet. 2018 Jul;55(7):431-441. doi: 10.1136/jmedgenet-2018-105337. Epub 2018 Jun 21. Review.

PMID:
29929997
17.

Soluble E-cadherin promotes tumor angiogenesis and localizes to exosome surface.

Tang MKS, Yue PYK, Ip PP, Huang RL, Lai HC, Cheung ANY, Tse KY, Ngan HYS, Wong AST.

Nat Commun. 2018 Jun 11;9(1):2270. doi: 10.1038/s41467-018-04695-7.

18.

MicroRNA-219-5p Promotes Tumor Growth and Metastasis of Hepatocellular Carcinoma by Regulating Cadherin 1.

Yang J, Sheng YY, Wei JW, Gao XM, Zhu Y, Jia HL, Dong QZ, Qin LX.

Biomed Res Int. 2018 May 15;2018:4793971. doi: 10.1155/2018/4793971. eCollection 2018.

19.

Decreased E-Cadherin in MCF7 Human Breast Cancer Cells Forming Multicellular Spheroids Exposed to Simulated Microgravity.

Sahana J, Nassef MZ, Wehland M, Kopp S, Krüger M, Corydon TJ, Infanger M, Bauer J, Grimm D.

Proteomics. 2018 Jul;18(13):e1800015. doi: 10.1002/pmic.201800015. Epub 2018 Jun 19.

PMID:
29785723
20.

Clinical and functional characterization of the CDH1 germline variant c.1679C>G in three unrelated families with hereditary diffuse gastric cancer.

Pena-Couso L, Perea J, Melo S, Mercadillo F, Figueiredo J, Sanches JM, Sánchez-Ruiz A, Robles L, Seruca R, Urioste M.

Eur J Hum Genet. 2018 Sep;26(9):1348-1353. doi: 10.1038/s41431-018-0173-8. Epub 2018 May 16.

Supplemental Content

Support Center